EUTM file information

018750229

WUVIKO


August 18, 2022

Trademark Summary

The trademark WUVIKO was filed by DIZAL (JIANGSU) PHARMACEUTICAL CO., LTD., a corporation established under the laws of the People's Republic of China (the "Applicant"). The application was published for oppositions on September 26, 2022, and received undefined oppositions.

Opposition Proceedings

There are undefined Oppositions claimed against trademark.

The first opposition filed on December 19, 2022 by ITALFARMACO S.p.A. on Likelihood of confusion. the opponent was represented by DRAGOTTI & ASSOCIATI S.R.L. and its proceedings were handled in English The second opposition filed on December 4, 2022 by Novartis AG on Likelihood of confusion. the opponent was represented by MILOJEVIC, SEKULIC & ASSOCIATES, S.L. and its proceedings were handled in English

The application was filed in English, and English was also language of all opposition proceedings (French was selected as the second language).


Goods And Services

  • The mark was filed in class 5 with following description of goods:
    1. Anti-cancer preparations
    2. Biological preparations for the treatment of cancer
    3. Chemical reagents for medical purposes
    4. Pharmaceutical preparations for the treatment of immune system related diseases and disorders
    5. Pharmaceutical preparations for treating malignant tumors
    6. Pharmaceutical preparations for use in chemotherapy
    7. Pharmaceutical preparations for suppressing tumors
    8. Pharmaceutical products for the treatment of cancer
    9. Pharmaceutical preparations and substances for the prevention of cancer
    10. Elixirs (pharmaceutical preparations).